Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma

Although a multicenter, randomized study indicated that induction chemotherapy (IC) with docetaxel/cisplatin/fluorouracil (TPF) before concurrent chemoradiotherapy (CCRT) improves survival outcomes, it remains unclear whether TPF is the best IC regimen for treating locoregionally advanced nasopharyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Fangzheng, Wang, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Quanquan, Sun, Tongxin, Liu, Min, Xu, Peng, Wu, Bin, Long, Aizawa, Rihito, Sakamoto, Masoto, Zhenfu, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710912/
https://www.ncbi.nlm.nih.gov/pubmed/29207632
http://dx.doi.org/10.18632/oncotarget.20017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710912/
https://www.ncbi.nlm.nih.gov/pubmed/29207632
http://dx.doi.org/10.18632/oncotarget.20017

Ejemplares similares